mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases

Recent advances in the research of the mammalian target of the rapamycin (mTOR) signalling pathway demonstrated that mTOR is a robust therapeutic target for ocular degenerative diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma. Although the exact mec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yipin, Fung, Nicholas Siu Kay, Lam, Wai-Ching, Lo, Amy Cheuk Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311918/
https://www.ncbi.nlm.nih.gov/pubmed/35883796
http://dx.doi.org/10.3390/antiox11071304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311918/
https://www.ncbi.nlm.nih.gov/pubmed/35883796
http://dx.doi.org/10.3390/antiox11071304

Ejemplares similares